Bod Australia (ASX: BDA)
Bod Australia (ASX: BDA) operates a skin care and natural medicines business focused on all natural, evidence based products. www.bodaustralia.com
Bod Australia issues first MediCabilis scripts under Europe’s largest medicinal cannabis project
Cannabis-focused healthcare company Bod Australia (ASX: BDA) has issued the first prescriptions for its MediCabilis product to UK patients parti...
Bod Australia receives record order for cannabinoid and hemp products
It’s been a busy week for Bod Australia (ASX: BDA) with the company following up its first UK MediCabilis prescriptions with news it had receive...
Bod Australia reveals ‘significant’ growth in medicinal cannabis prescriptions, more to come
Bod Australia (ASX: BDA) revealed this morning it has experienced “significant growth” in prescriptions for its medicinal cannabis product, with...
Bod Australia receives major capital boost via Health & Happiness Group’s innovation arm
Cannabis-focused healthcare company Bod Australia (ASX: BDA) has struck an exclusive agreement with investment fund NewH2 owned by Hong Kong-lis...
Bod Australia’s cannabis oil to be used in landmark PTSD trial
Cannabis-focused healthcare company Bod Australia (ASX: BDA) has announced it will supply its pharmaceutical-grade cannabis extract MediCabilis ...
Clinical trial highlights tolerability of Bod Australia’s medicinal cannabis product
A phase one clinical trial of a sublingual cannabis wafer developed by Bod Australia (ASX: BDA) has highlighted the tolerability and superiority...
Bod Australia posts record quarterly revenue thanks to new products, distribution deals
Skincare and health products developer Bod Australia (ASX: BDA) has posted a record revenue of $1.22 million for the last quarter of 2018, under...
Bod Australia gets green light to export growing medicinal cannabis product range
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has received the green light to export its patented sublingual form of medicina...
Chemist Warehouse adds Bod Australia’s cannabis oil MediCabilis to its shelves
Australia’s adoption of medicinal cannabis has taken another step forward after Bod Australia (ASX: BDA) announced it has begun dispensing MediC...
Cannabis Access Clinics looks to aid Australian patient access to medical cannabis
The theory behind medical cannabis is that it has the potential to soothe many of today’s ailments, with illnesses such as epilepsy, multiple sc...
Bod Australia hits major milestone in cannabis wafer trial
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has achieved what it calls a “world-first” in the clinical trial of its proprie...
Bod Australia kicks off phase 1 clinical trial for phytocomplex cannabis extract
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has stormed into a phase 1 clinical trial to test the safety, tolerability and ...
Bod Australia recruits Swisse director alongside growing medical cannabis trend
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has appointed a new executive chairman to spearhead its multifaceted growth spu...
Bod Australia receives early green light to commence cannabis clinical trial
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has surprised the market by announcing that it has secured ethics approval in a...
Bod Australia sets the stage for marketing medical cannabis oil in Australia
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has added yet another string to its commercial bow, by completing its first ord...
Bod Australia obtains improved place in shop window via Australian Pharmaceuticals Industries
One of Australia’s emergent developer and distributors of cosmetics and natural medicines, Bod Australia (ASX: BDA) has secured potentially bett...
Bod Australia gains approval to commence importing medicinal cannabis oil
Cosmetics and natural medicines company Bod Australia (ASX: BDA) has added another piece to its puzzle towards commencing production of medicina...
Bod Australia upscales natural medicines range in tandem with growing demand
Cosmetics-maker Bod Australia (ASX: BDA) has decided to upscale its sales and distribution efforts courtesy of a timely agreement with In2Pharma...
Bod to develop hemp-based manuka honey for global markets with Manuka Pharma
Bod Australia (ASX: BDA) will develop a hemp-based, high methylglyoxal manuka honey line to distribute to global markets after pinning down a he...
Bod partners with iX Biopharma to incorporate medicinal cannabis in WaferiX for trials
Bod Australia (ASX: BDA) has agreed to supply its medicinal cannabis extracts to speciality pharmaceutical company iX Biopharma (SGX: 42C) for u...
Bod Australia kicks off cannabis-based cosmetic development, anticipates 2018 market release
Bod Australia (ASX: BDA) and Linnea SA have kicked off exploratory work into developing cannabis-based formulas for a new cosmetics range, which...